Replies to post #54152 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

I don't ask about trial specifics or anything like that unless I'm in interview mode and about to write. So, nothing new on the company.

I was simply trying to find out when he'd be back and also sent him links to a few items that popped up yesterday. As expected, he'd already seen them.





In Reply to 'Ovidius'
Leo was pretty busy answering emails!
I got one too! So, I guess from your post its a formulation for the B trails soon to start. He said he was visited different venders. Didn't bother to ask for what or where, although he stated for recent PR'd trail.

Did ask him to update the website from the CEO message of 2012! :)
Hope now that they are getting paid, they are not slacking off!

anything else?

[John B]

I wonder if Leo is in India for this for Brilacidin:

•Ophthalmic infections: As disclosed in November (See press release dated November 4, 2013) 2013), the company has identified ocular infections, such as keratitis, as an area of unmet medical need and significant commercial potential, based on positive preclinical data supporting safety, antimicrobial efficacy, and prolonged residence time on the ocular surface with minimal systemic exposure. The Company has received proposals for the necessary formulation and will shortly select a manufacturer.